Cargando…

Biologika in der Asthmatherapie - was gibt es, was kommt?

Detalles Bibliográficos
Autor principal: Gillissen, Adrian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Medizin 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060840/
https://www.ncbi.nlm.nih.gov/pubmed/35531054
http://dx.doi.org/10.1007/s15033-022-2811-7
_version_ 1784698593044594688
author Gillissen, Adrian
author_facet Gillissen, Adrian
author_sort Gillissen, Adrian
collection PubMed
description
format Online
Article
Text
id pubmed-9060840
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Medizin
record_format MEDLINE/PubMed
spelling pubmed-90608402022-05-03 Biologika in der Asthmatherapie - was gibt es, was kommt? Gillissen, Adrian Pneumo News CME Fortbildung Springer Medizin 2022-05-03 2022 /pmc/articles/PMC9060840/ /pubmed/35531054 http://dx.doi.org/10.1007/s15033-022-2811-7 Text en © Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle CME Fortbildung
Gillissen, Adrian
Biologika in der Asthmatherapie - was gibt es, was kommt?
title Biologika in der Asthmatherapie - was gibt es, was kommt?
title_full Biologika in der Asthmatherapie - was gibt es, was kommt?
title_fullStr Biologika in der Asthmatherapie - was gibt es, was kommt?
title_full_unstemmed Biologika in der Asthmatherapie - was gibt es, was kommt?
title_short Biologika in der Asthmatherapie - was gibt es, was kommt?
title_sort biologika in der asthmatherapie - was gibt es, was kommt?
topic CME Fortbildung
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060840/
https://www.ncbi.nlm.nih.gov/pubmed/35531054
http://dx.doi.org/10.1007/s15033-022-2811-7
work_keys_str_mv AT gillissenadrian biologikainderasthmatherapiewasgibteswaskommt